Lenidase is developed by Gaetano Isola, DDS, PhD.

What development phase is Lenidase in?

Lenidase is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Lenidase

Gaetano Isola, DDS, PhD · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Lenidase
Also known as	Placebo
Sponsor	Gaetano Isola, DDS, PhD
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phytotherapy Agent in Third Molar Surgery (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Lenidase CI brief — competitive landscape report
Lenidase updates RSS · CI watch RSS
Gaetano Isola, DDS, PhD portfolio CI